A new T‐antigen negative HEK293 cell line with improved AAV productivity
Biotechnology and Bioengineering · 2023
DOI: 10.1002/bit.28414 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Coralie Croissant und 13 weiteren Autor:innen. Beteiligte Einrichtung: ExcellGene SA, Monthey, Switzerland. Hauptthemen laut MEDLINE: Antigens, Viral, Tumor, Genetic Vectors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Viral vectors for gene therapy, such as recombinant adeno‐associated viruses, are produced in human embryonic kidney (HEK) 293 cells. However, the presence of the SV40 T‐antigen‐encoding CDS SV40GP6 and SV40GP7 in the HEK293T genome raises safety issues when these cells are used in manufacturing for clinical purposes. We developed a new T‐antigen‐negative HEK cell line from ExcellGene's proprietary HEKExpress,® using the CRISPR‐Cas9 strategy. We obtained a high number of clonally‐derived cell populations and all of them were demonstrated T‐antigen negative. Stability study and AAV production evaluation showed that the deletion of the T‐antigen‐encoding locus did not impact neither cell growth nor viability nor productivity. The resulting CMC‐compliant cell line, named HEKzeroT,® is able to produce high AAV titers, from small to large scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ExcellGene SA, Monthey, Switzerland.
ORCID-Profile: Paco Pino
Zitieren
APA
Croissant, C., Armitano, J., Lazuech, B., Švec, D., Pugin, C., Guesdon, A., Bryan, L., Castro, A., Neuhaus, L., Fonti, G., Martinis, J., Wurm, M. J., Wurm, F. M., & Pino, P. (2023). A new T‐antigen negative HEK293 cell line with improved AAV productivity. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28414
Vancouver
Croissant C, Armitano J, Lazuech B, Švec D, Pugin C, Guesdon A, et al. A new T‐antigen negative HEK293 cell line with improved AAV productivity. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28414
BibTeX
@article{Croissant2023,
author = {Croissant, Coralie and Armitano, Joshua and Lazuech, Bertrand and Švec, Danijel and Pugin, Cyril and Guesdon, Anaïs and Bryan, Louise and Castro, Antonio and Neuhaus, Léa and Fonti, Giulia and Martinis, Jacopo and Wurm, Maria J and Wurm, Florian M and Pino, Paco},
title = {A new T‐antigen negative HEK293 cell line with improved AAV productivity},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28414}
}
EUVIMED